Microbot Medical Statistics
Microbot Medical (MBOT) Stock Statistics & Valuation Metrics
Total Valuation
Microbot Medical has a market cap or net worth of $49.92M. The enterprise value is $82.91T.
- Market Cap
- $49.92M
- Enterprise Value
- $82.91T
Share Statistics
Microbot Medical has 67,164,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 67,164,800
- Owned by Insiders
- 0.20%
- Owned by Institutions
- 13.03%
Financial Efficiency
Microbot Medical’s return on equity (ROE) is -0.17 and return on invested capital (ROIC) is -18.80%.
- Return on Equity (ROE)
- -0.17
- Return on Assets (ROA)
- -0.16
- Return on Invested Capital (ROIC)
- -18.80%
- Return on Capital Employed (ROCE)
- -0.19
- Revenue Per Employee
- 0
- Profits Per Employee
- -305.63K
- Employee Count
- 43
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Microbot Medical is -2.49. Microbot Medical’s PEG ratio is -0.04.
- PE Ratio
- -2.49
- PS Ratio
- 109.26
- PB Ratio
- 0.72
- Price to FCF
- -2.33
- Price to Operating Cash Flow
- -2.38
- PEG Ratio
- -0.04
Income Statement
In the last 12 months, Microbot Medical had revenue of 0 and earned -13.14M in profits. Earnings per share was -0.29.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -14.74M
- Pretax Income
- -13.14M
- Net Income
- -13.14M
- EBITDA
- -13.10M
- Earnings Per Share (EPS)
- -0.29
Cash Flow
In the last 12 months, operating cash flow was -19.21M and capital expenditures -390,000, giving a free cash flow of -19.60M billion.
- Operating Cash Flow
- -19.21M
- Free Cash Flow
- -19.60M
- Free Cash Flow per Share
- -0.29
Dividends & Yields
Microbot Medical pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -43.03%
- Earnings Yield
- -40.85%
Stock Price Statistics
- Beta
- 1.61
- 52-Week Price Change
- -60.69%
- 50-Day Moving Average
- 1.12
- 200-Day Moving Average
- 1.79
- Relative Strength Index (RSI)
- 33.34
- Average Volume (3m)
- 915.94K
Financial Position
Microbot Medical as a current ratio of 23.33, with Debt / Equity ratio of 1.12%
- Current Ratio
- 23.33
- Quick Ratio
- 23.16
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.23
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Microbot Medical has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Microbot Medical EV to EBITDA ratio is -2.30, with an EV/FCF ratio of -2.25.
- EV to Sales
- 105.46
- EV to EBITDA
- -2.30
- EV to Free Cash Flow
- -2.25
- EV to Operating Cash Flow
- -2.30
Balance Sheet
Microbot Medical has $61.83M in cash and marketable securities with $838.00K in debt, giving a net cash position of $60.99M billion.
- Cash & Marketable Securities
- $61.83M
- Total Debt
- $838.00K
- Net Cash
- $60.99M
- Net Cash Per Share
- $0.91
- Tangible Book Value Per Share
- $0.94
Margins
Gross margin is -404.78%, with operating margin of -5057.42%, and net profit margin of -4450.72%.
- Gross Margin
- -404.78%
- Operating Margin
- -5057.42%
- Pretax Margin
- -4450.72%
- Net Profit Margin
- -4450.72%
- EBITDA Margin
- -4591.15%
- EBIT Margin
- -4606.70%
Analyst Forecast
The average price target for Microbot Medical is $5.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $5.00
- Price Target Upside
- 635.29% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 4
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 38.89%
Scores
- Smart Score
- 6
- AI Score
- ―

